CMS Increases Medicare Payment for COVID-19 Monoclonal Antibody Infusions

CMS has increased the Medicare payment rates for administering monoclonal antibodies to treat beneficiaries with COVID-19, effective for services furnished on or after May 6, 2021. The rates are geographically adjusted based on where the service is furnished. To know these codes and their descriptions, read along!

You need to be logged in to view the rest of the content. Please . Not a Member? Join Us